Shanghai Yitai Pharmaceutical Technology Overview

  • Founded
  • 2016

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Shanghai Yitai Pharmaceutical Technology General Information


Provider of bio-pharmaceutical services intended to develop and commercialize innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases. The company's bio-pharmaceutical services include developing synthetic peptide analog of human parathyroid hormone-related protein (hPTHrP) which is a bone-building hormone and product for treatment of osteoporosis in both injection and trans dermal methods of administration, enabling doctors to cure their patients quickly.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 811 Huahong Business Center
  • 388 Daduhe Road No. 5
  • Shanghai, Putuo 200062
  • China

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shanghai Yitai Pharmaceutical Technology Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shanghai Yitai Pharmaceutical Technology‘s full profile, request access.

Request a free trial